Valeant Teams With Bill Ackman to Buy Allergan

April 23 (Bloomberg) -- Valeant offered to buy Allergan for about $152.89 a share in a cash-and-stock deal that will give the Canadian company the Botox wrinkle treatment. Stephanie Ruhle reports on Bill Ackman’s involvement on Bloomberg Television’s “In The Loop.” (Source: Bloomberg)
Will Kellogg’s Cereal Sales Ever Return to Normal?
45:04 - Feb. 27 -- Bloomberg Businessweek’s Devin Leonard reports on changes in the way American’s eat breakfast and the impact on the cereal sales. He speaks on “Market Makers.”
  • Bill Burns: Charlie Rose (02/27)
  • Extra Extra! NY Daily News May Be for Sale
  • Pending Home Sales Rebound, Consumer Confidence Lags